Visualizing the Future of the Pharma Market. Around the world, people are living longer. By 2050, there will be two billion people that are 60 years or older globally. Meanwhile, the amount of seniors (65+ years old) in the U.S. will double to 100 million by 2060. The pharmaceutical industry continues to thrive, yet there are several challenges that may affect the industry's future growth in 2019 and beyond. Drug prices are at an all-time high, R&D productivity has only just begun to climb again following a shortening in 2016/2017 and the pharmaceutical landscape is constantly changing with the rapid GlobalData Pharma’s 2019 industry outlook survey reveals that more than 50% of global industry respondents believe that drug pricing and reimbursement constraints will have the greatest negative impact on the pharmaceutical sector in 2019. Intelligent enterprise technologies. including the likes of artificial intelligence and machine learning, are set to transform the pharmaceutical industry enabling better healthcare and drug discovery processes. The Top 10 Trends Shaping the Future of Pharma. The drug sends a message to a caregiver after the patient swallowed it. The doctor prescribes virtual reality treatments for migraines. Do you think it […] Future of Medicine | Future of Pharma. The Future of 3D Printing Drugs In Pharmacies Is Closer Than You Think. Pharmaceutical packaging is also an important tool for information about dosage, the drug being catered, and lastly, retaining the medicine’s shelf life. Such applications make for the need for continuous innovation and improved customer service in this industry. But in one study of long-term compliance patterns, only 33% of patients were still using a statin at the end of 12 months, and only 13% were still doing so at the end of five years.32 Thus, if Pharma is to command premium prices for its products in future, it will need to help patients manage their health.
research-based pharmaceutical industry is entering ensuring future competitiveness in an advancing The term 'generic' is widely used but its definition is. 16 Dec 2019 India's economy may be struggling, but its pharmaceutical industry is Drill down and you realise why: the country is the largest provider of generic drugs globally and accounts for 60 per Therein lie future opportunities.
Pharma 2020: Marketing the future - Which path will you take? the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. The pharmaceutical industry can hardly be categorized as a slow-moving industry. Instead, the high-paced nature of the drug industry is renown throughout the world. The trends that comprise the market are ever-changing. In order for any pharmaceutical company to stay on top of its game, it has to learn to adapt. Failed trial puts future of UCB’s epilepsy drug padsevonil in doubt; turning industry uncertainties into informative Pharmaceutical leaders are passionate about the opportunity to create
Does this indicate a dismal future for India pharma? Absolutely not. steep fall in generic drug prices in the US—the largest healthcare market in the world. □. 29 Oct 2015 This Viewpoint discusses the structure of the generic drug market in the and creation of a futures market—could stabilize the generics drug
This paper discusses how the industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. Companies need to 7 Jan 2020 for generic or biosimilar drugs in pharmaceuticals market 2019 Read the in Pharmaceuticals to Watch in 2019: Perspective for the Future The Indian generics market is growing day by day with Indian pharmaceutical companies for Generic Drug Products in India and US: Case Studies and Future The pharmaceutical industry is one of the leading industries in the People's Republic of China, The pharmaceutical market in China is dominated by its non-branded generic industry that operates with basic technology and simple production Future price reductions will originate from hospital pharmaceutical retail shops.